TradeUP Acquisition (UPTDW) Competitors

$0.11

0.00 (0.00%)

(As of 09/13/2024 ET)

Stock Analysis Chart Competitors Financials SEC Filings Trends

UPTDW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, ACABU, BCAX, BFRIW, and BTMDW

Should you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Bicara Therapeutics (BCAX), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

TradeUP Acquisition vs.

180 Life Sciences (NASDAQ:ATNFW) and TradeUP Acquisition (NASDAQ:UPTDW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk.

: Company Net Margins Return on Equity Return on Assets
180 Life Sciences N/A N/A N/A
TradeUP Acquisition N/A N/A N/A
: 180 Life Sciences and TradeUP Acquisition both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
180 Life Sciences N/A N/A
TradeUP Acquisition N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
180 Life Sciences N/A N/A N/A N/A N/A
TradeUP Acquisition N/A N/A N/A N/A N/A
: In the previous week, 180 Life Sciences had 2 more articles in the media than TradeUP Acquisition. MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for TradeUP Acquisition. 180 Life Sciences' average media sentiment score of 1.44 beat TradeUP Acquisition's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.
Company Overall Sentiment
180 Life Sciences Positive
TradeUP Acquisition Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
TradeUP Acquisition
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A

Company	Net Margins	Return on Equity	Return on Assets
180 Life Sciences	N/A	N/A	N/A
TradeUP Acquisition	N/A	N/A	N/A

Company	Underperform	Outperform
180 Life Sciences	N/A	N/A
TradeUP Acquisition	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
180 Life Sciences	N/A	N/A	N/A	N/A	N/A
TradeUP Acquisition	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
180 Life Sciences	Positive
TradeUP Acquisition	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
TradeUP Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

180 Life Sciences beats TradeUP Acquisition on 2 of the 2 factors compared between the two stocks.

Ad Monetary Gold

Biden's Executive Order, Dems Digital Money Legislation, First Step To

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.

Get TradeUP Acquisition News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UPTDW vs. The Competition

Export to Excel

Metric	TradeUP Acquisition	Biological Products, Except Diagnostic Substances Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	N/A	$306.50M	$1.87B	$8.19B
Dividend Yield	N/A	2.44%	2.68%	4.10%
P/E Ratio	N/A	N/A	22.54	18.33
Price / Sales	N/A	N/A	482.71	68.98
Price / Cash	N/A	N/A	40.35	31.78
Price / Book	N/A	N/A	2.43	4.76
Net Income	N/A	N/A	$119.72M	$222.74M
7 Day Performance	-55.23%	N/A	16.12%	6.25%
1 Month Performance	N/A	N/A	18.26%	10.29%
1 Year Performance	-55.21%	0.04%	12.22%	13.23%

TradeUP Acquisition Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars 0.00 / 5 stars	$0.01 -19.2%	N/A	-58.8%	$0.00	N/A	7	Short Interest ↓ Positive News Gap Up
LBPSW 4D pharma	0 of 5 stars 0.00 / 5 stars	$0.04 -25.7%	N/A	N/A	$0.00	$522,000.00	N/A	Gap Down
AEHAW Aesther Healthcare Acquisition	0 of 5 stars 0.00 / 5 stars	$0.16 +6.2%	N/A	-76.3%	$0.00	N/A	2	Gap Down
AIMDW Ainos	0 of 5 stars 0.00 / 5 stars	$0.05 -27.0%	N/A	N/A	$0.00	$65,122.00	40	Positive News Gap Down
ALVOW Alvotech	0 of 5 stars 0.00 / 5 stars	$2.55 +2.0%	N/A	N/A	$0.00	$306.77M	4	Short Interest ↓
ACABW Atlantic Coastal Acquisition Corp. II	0 of 5 stars 0.00 / 5 stars	$0.04 -11.1%	N/A	N/A	$0.00	N/A	4	Gap Down High Trading Volume
ACABU Atlantic Coastal Acquisition Corp. II	0 of 5 stars 0.00 / 5 stars	$10.99 -1.9%	N/A	N/A	$0.00	N/A	4	Positive News
BCAX Bicara Therapeutics	0 of 5 stars 0.00 / 5 stars	$24.99 +6.7%	N/A	N/A	$0.00	N/A	32	Negative News High Trading Volume
BFRIW Biofrontera	0 of 5 stars 0.00 / 5 stars	$0.03 -20.5%	N/A	N/A	$0.00	$35.24M	70	Gap Down
BTMDW biote	0 of 5 stars 0.00 / 5 stars	$1.61 +15.8%	N/A	N/A	$0.00	$187.23M	N/A	Gap Up